Social Clips Last Week’s Top-3 Most Read Posts On Scleroderma Last Week’s Top-3 Most Read Posts On Scleroderma by admin | November 23, 2015 Share this article: Share article via email Copy article link Read the Articles Here: Genkyotex’s Systemic Sclerosis Therapy Granted Orphan Drug Designation Mycophenolate Mofitil Identified As Promising Scleroderma-Related Interstitial Lung Disease Treatment Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria Print This Page Tags Genkyotex, Intestinal Microbiome, mycophenolate mofitil
November 6, 2024 Columns by Tomisa Starr My scleroderma diagnosis journey: What a long, strange trip it’s been
November 5, 2024 News by Katherine Poinsatte Cool Comedy, Hot Cuisine raises $1.3M+ for scleroderma research
October 29, 2024 News by Patricia Inácio, PhD CAL101 treatment for scarring safe, well tolerated in Phase 1 trial
